SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.33 Cr | ₹0.96 Cr | ₹1.67 Cr | ₹2.27 Cr | - |
What is the latest Contingent Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.33 Cr |
Mar2023 | ₹0.96 Cr |
Mar2022 | ₹1.67 Cr |
Mar2021 | ₹2.27 Cr |
Mar2020 | - |
How is Contingent Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.33 Cr | 349.22 | |
Mar2023 | ₹0.96 Cr | -42.20 | |
Mar2022 | ₹1.67 Cr | -26.48 | |
Mar2021 | ₹2.27 Cr | 0 | |
Mar2020 | - | - |
Compare Contingent Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,201.3 Cr | 9.5% | 22.7% | 43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,971.0 Cr | -4.6% | 0.7% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,153.0 Cr | -1.2% | 12.6% | 51.2% | Stock Analytics | |
CIPLA | ₹122,717.0 Cr | 0.7% | 6% | 9.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,392.0 Cr | -1.8% | -0.4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,702.0 Cr | 4% | 8.9% | -1.3% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 9.5% |
22.7% |
43.7% |
SENSEX | 0.6% |
11% |
10.4% |
You may also like the below Video Courses